Oblimersen sets the scene for survival in CLL

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1619, 2008-01, pp. : 7-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oblimersen feasible in relapsed multiple myeloma

By  

Inpharma, Vol. 1, Iss. 1489, 2005-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Oblimersen: Augmerosen, BCL-2 Antisense Oligonucleotide - Genta, G 3139, GC 3139, Oblimersen Sodium

By Adis International Limited  

Drugs in R&D, Vol. 8, Iss. 5, 2007-01 ,pp. : 321-334

Adis International

Access to resources Recommend Favorite

Fludarabine + cyclophosphamide effective for CLL

By  

Inpharma, Vol. 1, Iss. 1598, 2007-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Fludarabine superior to chlorambucil in CLL

By  

Inpharma, Vol. 1, Iss. 1269, 2001-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Targeting Bcl-2 in CLL

By  

Current Medicinal Chemistry, Vol. 19, Iss. 30, 2012-10 ,pp. : 5109-5115

Bentham Science Publishers

Access to resources Recommend Favorite